Improved Pharma Showcasing Innovations at AAPS 2025
Meet us at Booth #3561 and posters M1030-04-26, M1330-08-54, and T1130-02-10.
Improved Pharma is gearing up for an exciting presence at AAPS 2025. This year, the company occupies a larger corner booth (#3561) adjacent to Varda Space Industries (#3563). The booth is strategically located on the main aisle of the exhibition floor, providing convenient access for attendees. A talented team from Improved Pharma, including Stephen Byrn, Pam Smith, Susan Bogdanowich-Knipp, Ruba Alajlouni, and Lauren Smith will be on hand to engage with visitors. Attendees are encouraged to stop by to discuss their research and development needs, learn more about innovative solid-state chemistry and formulation design, and delve into the intriguing topic of crystallization in microgravity.
Presenting Groundbreaking Research
In line with its commitment to advancing pharmaceutical science, Improved Pharma's latest research has been selected for a Special Poster Collection focusing on Amorphous Solid Dispersions. One of the highlights is a presentation by Dr. Pamela Smith, the Chief Operating Officer, who will discuss "The Use of Raman Mapping and Hot-Stage Microscopy to Detect Micro-Domains of Crystallinity in Amorphous Solid Dispersions of Nilotinib". This presentation is scheduled for a dedicated session featuring five selected posters that were handpicked by recognized expert Bill Williams, III, Ph.D., FAAPS from the University of Texas at Austin.
Details of the Presentation
This special session will take place from 10:30 AM to 11:25 AM at Poster Forum 4. Each participating author will have approximately 10 minutes allocated to present their work and engage with the audience through Q&A. In addition, Dr. Smith's poster will also be featured in the regular poster session on the following day at session T1130-02-10.
Collaborative Research Efforts
Improved Pharma has also partnered with BASF to produce a joint poster titled "Critical Insights into High Drug Load Amorphous Formulations: Challenges and Advanced Techniques". This joint effort will be presented by Dr. Nitin Kumar K. Swarnakar and is set for poster M1330-08-54. This collaborative research showcases the complexities encountered when scaling-up drug formulations, particularly emphasizing the impact of slight variations on dissolution results. The insights gathered from advanced tools, such as Raman mapping, are invaluable, providing essential information regarding the quality across different production batches.
About Improved Pharma
Improved Pharma is a pioneering research and information entity dedicated to optimizing pharmaceutical processes, methods, and formulations. The company offers services that encompass solid-state form studies, formulation design, synchrotron techniques, analytical testing, and expert consulting tailored for the development and protection of intellectual property matters. Established in 2006 by founders Stephen and Sarah Byrn, the firm has a rich history of innovation, having roots linked to SSCI.
Frequently Asked Questions
What is Improved Pharma presenting at AAPS 2025?
Improved Pharma will showcase its latest research on Amorphous Solid Dispersions and several innovative projects at their booth and through poster presentations.
Where can I find Improved Pharma at the event?
You can visit Improved Pharma at Booth #3561 and view their posters at specified locations throughout the exhibition.
Who are the representatives from Improved Pharma at AAPS 2025?
The team will include Stephen Byrn, Pam Smith, Susan Bogdanowich-Knipp, Ruba Alajlouni, and Lauren Smith.
What topics will Dr. Pamela Smith discuss in her presentation?
Dr. Pamela Smith will explore Raman Mapping and Hot-Stage Microscopy as techniques to identify crystallinity in Amorphous Solid Dispersions.
What is the goal of Improved Pharma's research efforts?
Improved Pharma aims to enhance pharmaceutical formulations and processes to ensure improved product quality and efficacy, ultimately contributing to better health outcomes.
